Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines

Journal of Medical Virology

Volumn 52, Issue 3, 1997, Pages 275-279

  De Souza, Vanda Akico Ueda Fick ^a,b   Pannuti, Cláudio Sérgio ^a   Sumita, Laura Masami ^a   De Andrade Jr , Heitor Franco ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Avidity; Immunoglobulin G; Measles; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; MEASLES VACCINE;

ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; PRESCHOOL CHILD; SEROCONVERSION; SEROLOGY;

EID: 1842336797     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9071(199707)52:3<275::aid-jmv7>3.0.co;2-%23     Document Type: Article

References (25)

1. Berry S, Hernandez H, Kanashiro R, Campos M, Azabache V, Gomez G, Gutierrez M, Weirs B, Quadros C, Halsey N (1992): Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants. Pediatric Infectious Disease Journal 11:822-827.
2. Blackburn NK, Besselaar TG, Schoub BD, O'Connell KF (1991): Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. Journal of Medical Virology 33:6-9.
3. Bolotovski VM, Grabowsky M, Clements CJ, Albrecht P, Brenner ER, Zargaryantzs AI, Litvinov SK, Mikheyeva IV (1994): Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine. International Journal of Epidemiology 23:1069-1077.
4. Eisen HN, Siskind GW (1964): Variations in affinities of antibodies during the immune response. Biochemistry 3:996-1008.
5. Erdman DD, Heath JL, Watson JC, Markowitz LE, Bellini WJ (1993): Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. Journal of Medical Virology 41:44-48.
6. Hayden GF (1979): Measles vaccine failure - a survey of causes and means of prevention. Clinical Pediatrics 18:155-167.
7. Hedman K, Rousseau SA (1989): Measurement of avidity of specific IgG for verification of recent primary rubella. Journal of Medical Virology 27:288-292.
8. Hedman K, Seppala I (1988): Recent rubella virus infection indicated by a low avidity of specific IgG. Journal of Clinical Immunology 8:214-221.
9. Hedman K, Lappalainen M, Seppäiä I, Mäkelä O (1989a): Recent primary toxoplasma infection indicated by low avidity of specific IgG. The Journal of Infectious Diseases 159:736-740.
10. Hedman K, Hietala J, Tiilikainen A, Hartikainen-Sorri AL, Räihä K, Suni J, Väänänen P, Pietiläinen M (1989b): Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (Avidity-ELISA) and by hemolysis typing. Journal of Medical Virology 27:293-298.
11. Hedman K, Lappalainen M, Söderlund M, Hedman L (1993): Avidity of IgG in serodiagnosis of infectious diseases. Reviews of Medical Microbiology 4:123-129.
12. Hidaka Y, Aoki T, Akeda H, Miyazaki C, Ueda K (1994): Serological and clinical characteristics of measles vaccine failure in Japan. Scandinavian Journal of Infectious Diseases 26:725-730.
13. Inouye S, Hasegawa A, Matsuno S, Katow S (1984): Changes in antibody avidity after virus infections: Detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. Journal of Clinical Microbiology 20:525-529.
14. Junker AK, Tilley P (1994): Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox. Journal of Medical Virology 43:119-124.
15. Mathias RG, Meekison WG, Arcand TA, Schechter MT (1989): The role of secondary vaccine failures in measles outbreaks. American Journal of Public Health 79:475-478.
16. Meurman O, Waris M, Hedman K (1992): Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection. Journal of Clinical Microbiology 30:1479-1484.
17. Nossal GJV (1992): The molecular and cellular basis of affinity maturation in the antibody response. Cell 68:1-2.
18. Pannuti CS, Souza VAUF, Takaoka N, Leme STS, Pereira CR, Carvalho RPS, Amato Neto V (1987): Interferência entre as vacinas anti-sarampo e antipoliomielite. Bulletin de la Oficina Sanitaria Panamericana 103:227-232.
19. Sabin AB, Arechiga AF, Castro JF, Sever JL, Madden DL, Shekarchi I, Albrecht P (1983): Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. Journal of the American Medical Association 249:2651-2662.
20. Souza VAUF, Pannuti CS, Sumita LM, Albrecht P (1991): Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with hemagglutination-inhibition, immunofluorescence and plaque neutralization tests. Revista do Instituto de Medicina Tropical de Sao Paulo 33:32-36.
21. Steiner LA, Eisen HN (1967): The relative affinity of antibodies synthesized in the secondary response. Journal of Experimental Medicine 126:1185-1205.
22. Thomas HIJ, Morgan-Capner P (1991): The use of antibody avidity measurements for the diagnosis of rubella. Reviews of Medical Virology 1:41-50.
23. Tuokko H (1995): Detection of acute measles infections by indirect and μ-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. Journal of Medical Virology 45:306-311.
24. Ward KN, Dhaliwal W, Ashworth KL, Clutterbuck EJ, Teo CG (1994): Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. Journal of Medical Virology 43:367-372.
25. World Health Organization - Expanded Program on Immunization (1988): Research into alternative measles vaccines in the 1990s. WHO/EPI/Gen/88.11.